Published in Blood Weekly, October 5th, 1998
In vitro studies have provided little consensus on the kinetic abnormality underlying the myeloid expansion of CML, a neoplastic disorder that originates in a primitive hematopoietic stem cell. The transplantation of human CML cells into non-obese diabetic mice with severe immunodeficiency disease...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.